)
Pay in 4 interest-free payments of $5.45 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Additional Phase 3 trials are still underway, including TRIUMPH-2 (evaluating retatrutide in adults with obesity and type 2 diabetes) and TRIUMPH-3 (evaluating cardiovascular outcomes), with results expected later in 2026
Insurance plans may cover the cost of treatment, but prior authorization and other requirements must be met
Various, NEJM & The Lancet Ready for longevity
55M people globally are affected by dementia, with 70% of that population having Alzheimers disease, which is characterized by the buildup of two proteins in the brain, amyloid and tau
US$ 24.68
US$ 20.78
US$ 22.56
US$ 25.62
